Hims & Hers Health Sees Q4 Revenue Jump 31%, Guides Q1 Revenue Below Estimates
Hims & Hers Health posted fourth-quarter revenue of $196.8 million, up 31% year-over-year, while GAAP net loss widened to $35.4 million from $27.8 million. It forecast first-quarter revenue of $190 million to $195 million, below analysts’ average estimate around $210 million.
1. Fourth-Quarter Results
Hims & Hers Health delivered Q4 net revenue of $196.8 million, representing 31% growth from $150.6 million a year earlier. The GAAP net loss widened to $35.4 million, or $0.17 per share, compared with a loss of $27.8 million, or $0.14 per share, in the prior-year quarter.
2. First-Quarter Guidance
Management guided Q1 revenue of $190 million to $195 million, trailing the consensus estimate of about $210 million. The company attributed the cautious outlook to ongoing marketing investments and anticipated seasonality in telehealth demand.
3. Growth Drivers
Revenue gains in Q4 were driven by a 28% increase in subscription-based telehealth services and a 45% rise in over-the-counter product sales. New customer additions reached 120,000 in the quarter, up 22% year-over-year, reflecting expansion in key markets.
4. Investor Implications
Weaker Q1 guidance could pressure shares as investors weigh near-term growth challenges against long-term subscription retention trends. Management emphasized margin improvements and cost controls as key focus areas for 2026.